Mark Bamforth Biography and Net Worth

Mark Bamforth founded Brammer Bio, a best-in-class viral vector contract and development manufacturing organization (CDMO) supporting cell and gene therapy innovators. Brammer’s team has grown rapidly from 110 in 2016 to over 600 today. Brammer is based in Alachua, FL, for process development and clinical manufacturing, and in Cambridge and Lexington, MA, for commercial manufacturing.

In 2010, Bamforth founded a biologics CDMO, Gallus BioPharmaceuticals, and acquired a world-class facility and team in St. Louis, MO, with a commercial supply agreement with Janssen. Gallus tripled through organic growth and merging with Laureate Biopharma. Gallus was sold to DPx Holdings B.V. in 2014.

Bamforth previously had 22 years of experience in the UK and USA running a diverse, global manufacturing operation and a pharmaceutical CMO business for Genzyme and served as a corporate officer for 9 years. He began his career as a petroleum engineer exploring for North Sea oil with Britoil, then as a chemical engineer in the whisky industry with Whitbread.
Bamforth serves on the boards of Avid Bioservices, MassBio, Wentworth Institute of Technology, and Entrepreneurial Scotland. He has a BS in Chemical Engineering from Strathclyde University and an MBA from Henley Management College.

What is Mark R. Bamforth's net worth?

The estimated net worth of Mark R. Bamforth is at least $1.21 million as of March 13th, 2020. Mr. Bamforth owns 100,000 shares of Avid Bioservices stock worth more than $1,214,000 as of November 17th. This net worth estimate does not reflect any other assets that Mr. Bamforth may own. Learn More about Mark R. Bamforth's net worth.

How do I contact Mark R. Bamforth?

The corporate mailing address for Mr. Bamforth and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected]. Learn More on Mark R. Bamforth's contact information.

Has Mark R. Bamforth been buying or selling shares of Avid Bioservices?

Mark R. Bamforth has not been actively trading shares of Avid Bioservices during the last quarter. Learn More on Mark R. Bamforth's trading history.

Who are Avid Bioservices' active insiders?

Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.

Are insiders buying or selling shares of Avid Bioservices?

In the last twelve months, Avid Bioservices insiders bought shares 1 times. They purchased a total of 23,000 shares worth more than $134,780.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 15 times. They sold a total of 50,858 shares worth more than $423,264.89. The most recent insider tranaction occured on October, 14th when insider Matthew R Kwietniak sold 119 shares worth more than $1,207.85. Insiders at Avid Bioservices own 3.1% of the company. Learn More about insider trades at Avid Bioservices.

Information on this page was last updated on 10/14/2024.